Results 221 to 230 of about 11,627,928 (311)
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens +6 more
wiley +1 more source
Multimodal Integration Identifies C16orf74 as an EMT Regulator With Prognostic Relevance in HNSCC. [PDF]
Huang Z +7 more
europepmc +1 more source
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur +11 more
wiley +1 more source
Exosome-mediated transfer of bta-miR-2484 upregulates JAK-STAT pathway to inhibit BoHV-1 replication by targeting SOCS5. [PDF]
Xu M +9 more
europepmc +1 more source
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington +10 more
wiley +1 more source
KUSp, a novel oral spindle cell squamous cell carcinoma cell line with epithelial-mesenchymal transition features and high invasive capacity. [PDF]
Kawahara K +14 more
europepmc +1 more source
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq +8 more
wiley +1 more source
Harnessing inflammatory monocytes to overcome resistance to anti-PD-1 immunotherapy. [PDF]
Zimmerman MP +24 more
europepmc +1 more source

